News | November 10, 2025
Novo Nordisk India partners with Emcure to commercialise Poviztra in India
Poviztra is a second brand of Wegovy
Poviztra is a second brand of Wegovy
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Dabur India has reported total income of Rs. 3,331.45 crore during the period ended September 30, 2025
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Novartis India has reported total income of Rs. 99.73 crore during the period ended September 30, 2025
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
Arora brings over 30 years of experience in the pharmaceutical and healthcare industry
The event will be attended by 35,000+ industry professionals
Subscribe To Our Newsletter & Stay Updated
